At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5,028 enrolled
Drug / intervention
Restrictive Transfusion Strategy +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An International, Multi-centre, Randomized Controlled Trial to Assess Transfusion Thresholds in Patients Undergoing Cardiac Surgery
In Brief
A clinical study evaluating Restrictive Transfusion Strategy and Liberal transfusion strategy for Disorder; Heart, Functional, Postoperative, Cardiac Surgery. Completed, enrolled 5,028 participants across 74 sites in 19 countries.
Detailed Summary
TRICS-III is an international, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in high risk patients having cardiac surgery using a non-inferiority trial design.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustralia, Brazil, Canada, China, Colombia, Denmark, Egypt, Germany, Greece, India, Israel, Malaysia, New Zealand, Romania, Singapore, South Africa, Spain, Switzerland, United States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJan 2014
First PostedJan 2014
Primary CompletionApr 2017
Study CompletionOct 2017
TodayJul 2026
First PostedJan 23, 2014
Enrollment StartJan 20, 2014
Primary CompletionApr 28, 2017
Study CompletionOct 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 12.4 years ago
Interventions
Restrictive Transfusion Strategyother
Liberal transfusion strategyother